The results showed that decreased expression of BMP-7 leads to the progression of uveal melanoma, whereas the tumors overexpressing BMP-7 have relatively limited invasion, usually confined to and around the lens, suggesting BMP-7 may be a novel therapeutic molecule to inhibit the growth of uveal melanoma [81]. The gene discussed is BMP7; the disease is uveal melanoma.